建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?
-
開啟新分頁(紅色框)
-
於搜尋框中打入Edge(紅色框)，並按搜尋(藍色框)
-
點擊【立即啟動】(藍框處)打開 Microsoft Edge
Title
Oneness Board of Directors resolved to convene the Annual Shareholders' Meeting of 2025.
The Board of Directors resolved not to distribute dividends.
The Company's 2024 consolidated financial statements have been approved by the Board of Directors
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its Board of Directors resolve not to distribute dividends
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its BOD resolution to convene the 2025 Annual Shareholders’meeting
Announcement of the date of the Company's board of directors meeting for the year ended December 31, 2024 Parent Company Only and Consolidated Financial Reports
Oneness Biotech to Present at Healthcare Conference Taipei 2025
News-Oneness Listed in the S&P Global Sustainability Yearbook for the Third Consecutive Year, Ranking Among the Top 10 in the Global "Pharmaceuticals Industry" for 2025
Oneness Biotech Co., LTD receives a China patent on antagonistic LAG-3 aptamers.
Oneness Biotech Co., Ltd., had been granted with MDSAP (Medical Device Single Audit Program) certification for medical device quality management system.
The board of directors of the Company approved a resolution on the 1st issue of the employee stock option certificate of 2025.
Oneness Biotech Co., Ltd. receives a Chinese patent titled "TREATING IGE-MEDIATED ALLERGIC DISEASES"on FB825.
Oneness Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Oneness Nanchou manufacturing site has passed the GMP compliance assessment of foreign pharmaceutical manufacturers reviewed by the DAV
建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?